11Mon·

$KTN (-1.58%) Kontron expects further growth.


Preliminary figures for the past year indicate a strong fourth quarter, announced the SDax listed company from Linz. Kontron expects to have exceeded its targets for 2023 as a whole.


Kontron is forecasting an increase in net profit to over EUR 87 million for 2024. Compared to the EUR 72 million that the company has forecast for 2023, this would be an increase of around one fifth. Turnover is expected to increase to over EUR 1.4 billion.


Group CEO Hannes Niederhauser is convinced that "the 2024 financial year will be another very good year". The order books are full. Kontron's development into a pure IoT provider is "a complete success".


The 2023 II share buyback program announced at the end of September is also running with weekly updates - which pleases shareholders 😁


In the meantime, 1,764,268 shares have already been bought back since the beginning of October. And more are being bought back every week - according to the program, up to 4 million shares are to be repurchased🚀


Who here is also invested in SDax companies?


Source: Investing.com and Aktienrückkaufprogramm_II_2023 | Kontron Investor Relations

attachment
13
17 Comments

profile image
I'm also involved and looking forward to the development in 2024 with possible further buybacks👍
2
View all 3 further answers
Entered at 20.46, am curious about the development
2
profile image
I got in this morning.
Stop loss is set and now I am curious to see how things will continue. The statements from the CEO are of course good, but let's see what the quarterly figures reveal. Do you know when they will be published?
1
View all 5 further answers
profile image
I'm in too. Really a very promising value 👍
1
profile image
There are rumors of further acquisitions at Kontron.
I've had it on my watch for some time.
But I haven't had any good experiences with the Alpine republic.
1
Show answer
profile image
In the depot for some time
1
profile image
8Mon
The share is struggling a bit again, although the current figures look good. The market reaction doesn't quite make sense to me... hmmm
Show answer
Join the conversation